Event Date: May 12, 2020
This webinar will enable you to better characterize the maximum tolerated dose to improve your probability of success in later trials.
At the end of the webinar you will be able to:
- Simulate and analyse Phase 1 dose escalation trials for determining maximum tolerated dose (MTD)
- Understand a range of different methodologies that are used in Phase 1 dose escalation trials
- Communicate findings to the clinical team using East’s intuitive graphs and tables
- Simulate a dose escalation design followed by single-arm cohort expansion
Presenter:
- Pantelis Vlachos, Principal, Strategic Consulting, Cytel
Click here for additional information and registration details.